X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.


Latest Post

September 02, 2020

SARS-CoV-2 Vaccines – Alternative Vial Components

The need to provide vaccines for the SARS-CoV-2 pandemic has presented the pharmaceutical industry with unprecedented challenges. Among them are accelerated timelines for development/approval and unanticipated volumes for manufacture/delivery. Ordinarily for a new drug product, there is ample time for selecting the primary package system and establishing component availability.
Whitney Winters

Whitney Winters

Sr. Director, Strategic Marketing, Containment Systems

Categories

Search the Blog

Archive

{1}

{2}
{3}

{4}

  • Previous Posts
    Bettine Boltres presents at PDA Webinar

    August 24, 2020

    How to Include Elastomers in the Nitrosamine Risk Assessment

    Bettine Boltres

    Dr. Bettine Boltres

    Principal Scientific Affairs, Packaging & Delivery Systems

    Stoppers

    August 03, 2020

    Elastomer Stoppers – Performance

    Mary Tan

    Mary Tan

    Specialist, Scientific Affairs, Jurong

    By Your Side for Service

    July 15, 2020

    Additional Products Now Available on West’s Online Store

    Carol Mooney

    Carol Mooney

    Director, Commercial, Digital & Transformation

    P3 Vials

    April 17, 2020

    Light Sensitive Drug Products Need Protection

    Nico Brandes

    Nico Brandes

    Director, Product Management, Vial Containment & Prefillable Systems

    Load more